---
figid: PMC3442742__jpr-5-279f1
figlink: /pmc/articles/PMC3442742/figure/f1-jpr-5-279/
number: F1
caption: 'NGF signaling pathways in mediating neurotrophic and nociceptor effects.Notes:
  NGF signals through the high-affinity TrkA and low p75NTR receptors. TrkA activates
  both PI3 kinase (PI3K) and Ras pathways, which lead to cell survival and neurite
  outgrowth. Signaling through p75NTR leads to apoptosis, which is blocked by the
  TrkA-activated PI3K pathway. PI3K activation also leads to activation of the nonselective
  cation channel TRPV1 by phosphorylation, thereby generating action potential for
  nociceptive functions. Moreover, TRPV1 phosphorylation results in increased translocation
  of TRPV1 to the plasma membrane to enhance channel activity. Antibody-mediated NGF
  blockade results in the abolition of both neurotrophic and nociceptor functions.Abbreviation:
  NGF, nerve growth factor.'
pmcid: PMC3442742
papertitle: NGF â€“ the TrkA to successful pain treatment.
reftext: Vinayak Kumar, et al. J Pain Res. 2012;5:279-287.
pmc_ranked_result_index: '106774'
pathway_score: 0.9578431
filename: jpr-5-279f1.jpg
figtitle: 'NGF signaling pathways in mediating neurotrophic and nociceptor effects.Notes:
  NGF signals through the high-affinity TrkA and low p75NTR receptors'
year: '2012'
organisms: Homo sapiens
ndex: b270756f-dedb-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3442742__jpr-5-279f1.html
  '@type': Dataset
  description: 'NGF signaling pathways in mediating neurotrophic and nociceptor effects.Notes:
    NGF signals through the high-affinity TrkA and low p75NTR receptors. TrkA activates
    both PI3 kinase (PI3K) and Ras pathways, which lead to cell survival and neurite
    outgrowth. Signaling through p75NTR leads to apoptosis, which is blocked by the
    TrkA-activated PI3K pathway. PI3K activation also leads to activation of the nonselective
    cation channel TRPV1 by phosphorylation, thereby generating action potential for
    nociceptive functions. Moreover, TRPV1 phosphorylation results in increased translocation
    of TRPV1 to the plasma membrane to enhance channel activity. Antibody-mediated
    NGF blockade results in the abolition of both neurotrophic and nociceptor functions.Abbreviation:
    NGF, nerve growth factor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BRAF
  - PRKCA
  - PDK1
  - RAF1
  - PRKCB
  - NGFR
  - ARAF
  - PRKCD
  - PRKD3
  - MAPK3
  - MAPK1
  - PRKCG
  - MAP2K1
  - NGF
  - PRKCZ
  - PRKCQ
  - AKT3
  - PRKCH
  - AKT2
  - PRKCE
  - AKT1
  - KRAS
  - MAP2K2
  - PRKCI
  - NTRK1
  - HRAS
  - NRAS
  - TRPV1
  - Ceramide
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: P75NTR
  symbol: p75NTR
  source: hgnc_alias_symbol
  hgnc_symbol: NGFR
  entrez: '4804'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: NGF
  symbol: NGF
  source: hgnc_symbol
  hgnc_symbol: NGF
  entrez: '4803'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: TrkA
  symbol: TRKA
  source: hgnc_alias_symbol
  hgnc_symbol: NTRK1
  entrez: '4914'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: TRPV1
  symbol: TRPV1
  source: hgnc_symbol
  hgnc_symbol: TRPV1
  entrez: '7442'
chemicals:
- word: Ceramide
  source: MESH
  identifier: D002518
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3442742__F1
redirect_from: /figures/PMC3442742__F1
figtype: Figure
---
